Doug Hastings, the Chair Emeritus of Epstein Becker & Green, P.C., is a nationally recognized health care transaction lawyer and adviser on health system change. For more than 30 years, Mr. Hastings and his colleagues at Epstein Becker Green have designed, implemented, and successfully closed scores of complex health care transactions on behalf of hospitals, health systems, academic medical centers, post-acute providers, large medical groups, and health plans. He advises clients on the strategic considerations, corporate architecture, and regulatory compliance components of proposed transactions, including the payment and delivery reform, governance, antitrust, exempt tax, and fraud and abuse implications.
Mr. Hastings served on the Board on Health Care Services of the Institute of Medicine (IOM) from 2003-11 and on the IOM's Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care from 2010-13. He is a Past President and Fellow of the American Health Lawyers Association. Named in 2006 as the first Chair of the Board of Directors of Epstein Becker Green, Mr. Hastings served in that role until January 2014.
Currently, Mr. Hastings serves as a member of the Board of Directors of Guthrie Health and the Quality and Community Benefit Committee of Riverside Health System. In 2013, he was elected to membership in the Healthcare Executives Study Society, a group primarily comprised of large health system CEOs that seeks to advance the state and art of executive leadership and influence the development of health care public policy.
He earned a B.A. from Duke University and his J.D. from the University of Virginia Law School.
Mr. Hastings is the co-author of the Bloomberg BNA Health Law & Business Portfolio Series No. 2300, Regulation of Provider Risk Sharing and Other Limitations on Risk Bearing Provider Networks.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)